The story of the erectile dysfunction drug presents a complex picture for shareholders. While the initial introduction generated massive get more info profits, the expiration of its patent opened the floodgates to cheaper competitors, dramatically reducing revenue. This poses a specific dilemma for drug manufacturers banking on related blockbuster

The story of Viagra, and its developer copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in income, its intellectual property lapse created a flood of lower-priced alternatives , significantly eroding its market share . While specific businesses may try to capitalize on similar conditions , the p